MOCH KENNETH I 4
4 · Zynerba Pharmaceuticals, Inc. · Filed Aug 5, 2021
Insider Transaction Report
Form 4
MOCH KENNETH I
Director
Transactions
- Award
Common Stock
2021-08-03+5,000→ 5,000 total - Award
Stock Option (right to buy)
2021-08-03+7,500→ 7,500 totalExercise: $4.44Exp: 2031-08-03→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]The restricted stock award vests in full upon the earlier of (i) August 3, 2022, or (ii) the day before the Company's 2022 annual meeting of stockholders.
- [F2]The option vests in full upon the earlier of (i) August 3, 2022, or (ii) the day before the Company's 2022 annual meeting of stockholders.